Literature DB >> 18370536

Severe Thrombocytopenia Caused by Simvastatin in which Thrombocyte Recovery was Initiated after Severe Bacterial Infection.

T Yamada1, K Shinohara, K Katsuki.   

Abstract

Entities:  

Year:  1998        PMID： 18370536     DOI： 10.2165/00044011-199816020-00011

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  7 in total

1.  Interleukin-1 beta (IL-1 beta) induces thrombocytosis in mice: possible implication of IL-6.

Authors:  H Kimura; T Ishibashi; Y Shikama; A Okano; Y Akiyama; T Uchida; Y Maruyama
Journal:  Blood       Date:  1990-12-15       Impact factor: 22.113

2.  In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets.

Authors:  S Asano; A Okano; K Ozawa; T Nakahata; T Ishibashi; K Koike; H Kimura; Y Tanioka; A Shibuya; T Hirano
Journal:  Blood       Date:  1990-04-15       Impact factor: 22.113

Review 3.  HMG-CoA reductase inhibitors for treatment of hypercholesterolemia.

Authors:  S M Grundy
Journal:  N Engl J Med       Date:  1988-07-07       Impact factor: 91.245

4.  [Effect of the inhibitors of 3-hydroxy-3-methylglutaryl coenzyme-A reductase, pravastatin and simvastatin, on colony formation by hematopoietic progenitor cells].

Authors:  M Kunitama; N Komatsu; Y Miura
Journal:  Rinsho Ketsueki       Date:  1996-11

5.  Elevated serum interleukin-6 levels in patients with reactive thrombocytosis.

Authors:  C W Hollen; J Henthorn; J A Koziol; S A Burstein
Journal:  Br J Haematol       Date:  1991-10       Impact factor: 6.998

6.  Thrombocytopenic purpura during therapy with simvastatin.

Authors:  G Possamai; P Bovo; M Santonastaso
Journal:  Haematologica       Date:  1992 Jul-Aug       Impact factor: 9.941

7.  Effects of interleukin-1 and tumor necrosis factor on megakaryocytopoiesis: mechanism of reactive thrombocytosis.

Authors:  K Dan; S Gomi; K Inokuchi; K Ogata; T Yamada; I Ohki; S Hasegawa; T Nomura
Journal:  Acta Haematol       Date:  1995       Impact factor: 2.195
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.